Invention Grant
- Patent Title: Deuterated CFTR potentiators
-
Application No.: US16660426Application Date: 2019-10-22
-
Publication No.: US10894773B2Publication Date: 2021-01-19
- Inventor: Adam J. Morgan
- Applicant: Vertex Pharmaceuticals (Europe) Limited
- Applicant Address: GB London
- Assignee: Vertex Pharmaceuticals (Europe) Limited
- Current Assignee: Vertex Pharmaceuticals (Europe) Limited
- Current Assignee Address: GB London
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP.
- Main IPC: C07D215/56
- IPC: C07D215/56 ; C07B59/00
Abstract:
This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
Public/Granted literature
- US20200290971A1 DEUTERATED CFTR POTENTIATORS Public/Granted day:2020-09-17
Information query
